Success Stories: NAILG Achieves Swift EB-1A Approval for a Senior Lecturer in International Entrepreneurship (Premium Processing)

Client’s Testimonial:

“I truly appreciate your outstanding service and support throughout this process. Your guidance and professionalism have been invaluable, and I am deeply grateful for your efforts.”

On April 1^st, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Lecturer in the Field of International Entrepreneurship (Approval Notice).

General Field: International Entrepreneurship

Position at the Time of Case Filing: Senior Lecturer

Country of Origin: Iran

Country of Residence at the Time of Filing: United Kingdom

Approval Notice Date: April 1^st, 2025

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

The North America Immigration Law Group (NAILG) is pleased to announce the successful EB-1A approval of a distinguished researcher whose work is redefining the field of international entrepreneurship. His cutting-edge studies in innovation management, digital transformation, and entrepreneurial strategies have not only advanced academic knowledge but also provided practical frameworks for small and medium-sized enterprises (SMEs) operating in volatile markets worldwide.

Our client partnered with NAILG to pursue an EB-1A (Alien of Extraordinary Ability) petition through premium processing. After a comprehensive evaluation of his academic achievements and research influence, our legal team crafted a strong petition that earned USCIS approval in just 13 days.

To support his case, we presented extensive evidence of his outstanding contributions:

● Authorship of 66 peer-reviewed journal articles, along with book chapters and books that have shaped the discourse in entrepreneurship and international business.
● An impressive citation count of 4,419, placing him in the top 0.1% most cited scholars in international business over the past decade.
● 32 peer reviews for leading journals, confirming his recognized expertise in evaluating innovative research.
● Editorial board service across several respected journals further demonstrates his leadership role in the field.

Throughout the petition, we emphasized how his research addresses real-world challenges, particularly the digital transformation of businesses, strategic decision-making under uncertainty, and enhancing SME competitiveness. His methods, ranging from intuitionistic fuzzy analysis to advanced econometric modeling, have become essential tools for both academics and practitioners seeking to navigate rapidly changing global markets. One recommender captured the significance of his influence, stating:

“Without a doubt, it is clear that [client] stands at the top of international entrepreneurship research, given his achievements in developing comprehensive frameworks for digital transformation, innovative analytical methods using intuitionistic fuzzy analysis, and implementing strategic frameworks that improve SME performance. [Client]’s publication history both serves to highlight the impact of his work and also provides a virtual guarantee of his ability to continue producing meaningful works.”

The rapid approval of this petition reflects not only the strength of our client’s qualifications but also the clarity with which NAILG demonstrated his national and international acclaim. We highlighted how his future work will continue benefiting U.S. economic growth, technological advancement, and entrepreneurship development. We congratulate him on this well-earned success and look forward to the continued impact of his research in shaping the future of global business and innovation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.